Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
6,763 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00558363 | ARTS - AVODART After Radical Therapy For Prostate Cancer Study(ARTS) | completed | Phase 2 | 294 | GlaxoSmithKlineINDUSTRY | 9 | Mar 21, 2012 | clinicaltrials |
| NCT00061919 | Carboplatin and Etoposide With or Without Thalidomide in Treating Patients With Limited-Stage or Extensive-Stage Small Cell Lung Cancer | completed | Phase 3 | 724 | University College, LondonOTHER | 1 | Mar 16, 2012 |
| NCT00094029 | A Treatment Protocol for Patients With Gastrointestinal Stromal Tumor (GIST) Who May Derive Benefit From Treatment With SU011248 | approved for marketing | — | — | PfizerINDUSTRY | 34 | Mar 9, 2012 | clinicaltrials |
| NCT00130897 | Treatment Use Study With Sunitinib (SU011248) For Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma | approved for marketing | — | — | PfizerINDUSTRY | 50 | Mar 9, 2012 | clinicaltrials |
| NCT00003279 | Vaccination Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer(SILVA) | completed | Phase 3 | 500 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 10 | Mar 6, 2012 | clinicaltrials |
| NCT00003304 | Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors | completed | Phase 2 | 29 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 12 | Mar 6, 2012 | clinicaltrials |
| NCT00003643 | Combination Chemotherapy in Treating Men With Germ Cell Cancer | unknown | Phase 2 / Phase 3 | 498 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 14 | Mar 6, 2012 | clinicaltrials |
| NCT00101660 | Study of BMS-354825 (Dasatinib) in Patients With Chronic Myeloid Leukemia Who Are Either Resistant or Intolerant to Imatinib | completed | Phase 2 | 387 | Bristol-Myers SquibbINDUSTRY | 22 | Mar 2, 2012 | clinicaltrials |
| NCT00813072 | Study of PEP02, Irinotecan or Docetaxel in Gastric or Gastroesophageal Junction Adenocarcinoma | completed | Phase 2 | 135 | PharmaEngineINDUSTRY | 6 | Mar 2, 2012 | clinicaltrials |
| NCT00989105 | Technetium Tc 99m Demobesin-4 for Imaging Procedures in Patients With Prostate Cancer | terminated | Phase 1 | 8 | Cancer Research UKOTHER | 1 | Feb 28, 2012 | clinicaltrials |
| NCT01132599 | Comparing PET-CT Using C-11 Choline and 18F-Fluoromethylcholine in Patients With Metastatic Prostate Cancer | withdrawn | Phase 2 | 0 | Cancer Research UKOTHER | 1 | Feb 28, 2012 | clinicaltrials |
| NCT01147991 | Vaccine Therapy in Treating Patients With Epstein-Barr Virus-Related Cancer | completed | Phase 1 | 16 | Cancer Research UKOTHER | 1 | Feb 28, 2012 | clinicaltrials |
| NCT01212887 | Treated Blood Cells, Cyclophosphamide, Fludarabine Phosphate, and Aldesleukin in Treating Patients With Cancer | terminated | Phase 1 | 14 | Cancer Research UKOTHER | 1 | Feb 28, 2012 | clinicaltrials |
| NCT01092988 | A Clinical Study to Evaluate Safety of the ExAblate 2100 UF V2 System in the Treatment of Symptomatic Uterine Fibroids | completed | N/A | 40 | InSightecINDUSTRY | 4 | Feb 22, 2012 | clinicaltrials |
| NCT00040014 | Open Label, Multicenter, Randomized, Controlled Study of IM or Oral Exemestane (Aromasin) in Postmenopausal Women | terminated | Phase 2 | 100 | PfizerINDUSTRY | 1 | Feb 16, 2012 | clinicaltrials |
| NCT00969033 | CS-1008 Used With Irinotecan Versus Irinotecan Alone in Subjects With Metastatic Colorectal Carcinoma Who Failed First-line Treatment With Oxaliplatin | terminated | Phase 2 | 8 | Daiichi SankyoINDUSTRY | 1 | Jan 31, 2012 | clinicaltrials |
| NCT00608907 | An Open-Label Study to Assess the Effect of CYP3A4 Induction on the Pharmacokinetics of VELCADE (Bortezomib) | completed | Phase 1 | 61 | Millennium Pharmaceuticals, Inc.INDUSTRY | 5 | Jan 30, 2012 | clinicaltrials |
| NCT00283062 | Adjuvant Leuprolide With or Without Docetaxel in High Risk Prostate Cancer After Radical Prostatectomy | completed | Phase 3 | 228 | SanofiINDUSTRY | 17 | Jan 26, 2012 | clinicaltrials |
| NCT00501735 | Forodesine in the Treatment of Cutaneous T-Cell Lymphoma | completed | Phase 2 | 144 | BioCryst PharmaceuticalsINDUSTRY | 10 | Jan 23, 2012 | clinicaltrials |
| NCT00003212 | Ifosfamide or Doxorubicin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma | completed | Phase 3 | 780 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 10 | Jan 20, 2012 | clinicaltrials |
| NCT00048230 | PS-341 (VELCADE™) Versus High-Dose Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma | completed | Phase 3 | 620 | Millennium Pharmaceuticals, Inc.INDUSTRY | 13 | Jan 13, 2012 | clinicaltrials |
| NCT00063726 | A Study of PS-341 Given to Patients With Multiple Myeloma Who Experienced Progressive Disease After Receiving Dexamethasone in M34101-039 | completed | Phase 3 | 600 | Millennium Pharmaceuticals, Inc.INDUSTRY | 13 | Jan 13, 2012 | clinicaltrials |
| NCT00895726 | Pilot Study of APD209 in Cancer Cachexia | completed | Phase 2 | 13 | Acacia Pharma LtdINDUSTRY | 1 | Jan 13, 2012 | clinicaltrials |
| NCT00020696 | Tirapazamine Plus Cisplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Primary Peritoneal Cancer | completed | Phase 2 | — | Gynecologic Oncology GroupNETWORK | 4 | Jan 10, 2012 | clinicaltrials |
| NCT01492270 | Imaging for Significant Prostate Cancer Risk Evaluation(PICTURE) | unknown | N/A | 126 | University College London HospitalsOTHER | 1 | Dec 30, 2011 | clinicaltrials |
| NCT00512746 | Screening for Lung Cancer in Current or Past Smokers With Chronic Obstructive Pulmonary Disease | completed | N/A | 1,569 | University College, LondonOTHER | 1 | Dec 21, 2011 | clinicaltrials |
| NCT00554775 | WBRT & Erlotinib in Advanced NSCLC and Brain Metastases(TACTIC) | terminated | Phase 2 | 80 | University College, LondonOTHER | 1 | Dec 12, 2011 | clinicaltrials |
| NCT00866762 | A Study of the Efficacy of MK-0683 in Patients With Polycythaemia Vera and Essential Thrombocythaemia | unknown | Phase 2 | 60 | Copenhagen University Hospital at HerlevOTHER | 4 | Dec 12, 2011 | clinicaltrials |
| NCT01313390 | Everolimus and Docetaxel in Treating Patients With Recurrent, Locally Advanced, or Metastatic Head and Neck Cancer(DORA) | terminated | Phase 1 / Phase 2 | 4 | University College, LondonOTHER | 1 | Dec 12, 2011 | clinicaltrials |
| NCT00895297 | Efficacy and Safety Study of Dasatinib in Patients With Chronic Myeloid Leukemia(Dasatinib) | terminated | Phase 2 | 50 | European Society for Blood and Marrow TransplantationNETWORK | 4 | Dec 7, 2011 | clinicaltrials |
| NCT00460551 | Zalutumumab in Combination With Chemo-Radiation in a Certain Type of Lung Cancer | terminated | Phase 2 | 13 | GenmabINDUSTRY | 5 | Dec 6, 2011 | clinicaltrials |
| NCT01127542 | RESPeCT: Revlimid Early Stage Poor Prognosis Chronic Lymphocytic Leukaemia (CLL) Trial(RESPeCT) | terminated | Phase 2 | 1 | The Christie NHS Foundation TrustOTHER | 1 | Dec 5, 2011 | clinicaltrials |
| NCT01227135 | Imatinib Mesylate With or Without Hydroxychloroquine in Treating Patients With Chronic Myeloid Leukemia | unknown | Phase 2 | 66 | Lynn McMahonOTHER | 1 | Nov 30, 2011 | clinicaltrials |
| NCT00697879 | Safety Study of the Histone Deacetylase Inhibitor, CHR-3996, in Patients With Advanced Solid Tumours | completed | Phase 1 | 40 | Chroma TherapeuticsINDUSTRY | 2 | Nov 28, 2011 | clinicaltrials |
| NCT01242943 | Radioimmunotherapy With 131I-L19SIP in Patients With Cancer | terminated | Phase 1 / Phase 2 | 34 | Philogen S.p.A.INDUSTRY | 2 | Nov 22, 2011 | clinicaltrials |
| NCT00002763 | High-Dose or Low-Dose Interferon Alfa Compared With No Further Therapy Following Surgery in Treating Patients With Stage III Melanoma | unknown | Phase 3 | 1,000 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 21 | Nov 16, 2011 | clinicaltrials |
| NCT00174655 | BIG 02/98 Docetaxel - Breast Cancer | completed | Phase 3 | 2,887 | SanofiINDUSTRY | 21 | Nov 10, 2011 | clinicaltrials |
| NCT00518895 | Trial of Dacarbazine With or Without Genasense in Advanced Melanoma(AGENDA) | completed | Phase 3 | 300 | Genta IncorporatedINDUSTRY | 12 | Nov 7, 2011 | clinicaltrials |
| NCT00784810 | A Study to Compare Oxycodone/Naloxone Prolonged Release Against Codeine/Paracetamol in the Treatment of Moderate to Severe Chronic Low Back Pain or Pain Due to Osteoarthritis | completed | Phase 4 | 247 | Napp Pharmaceuticals LimitedINDUSTRY | 1 | Nov 2, 2011 | clinicaltrials |
| NCT00395434 | Safety Study of Increasing Doses of Combretastatin in Combination With Bevacizumab (Avastin) in Patients With Advanced Solid Tumors | completed | Phase 1 | 20 | Mateon TherapeuticsINDUSTRY | 1 | Oct 31, 2011 | clinicaltrials |
| NCT00977210 | Safety Study of OXi4503 (a Vascular Disrupting Agent) Given by 3 x Weekly Intravenous Infusions to Patients With Advanced Solid Tumors | completed | Phase 1 | 40 | Mateon TherapeuticsINDUSTRY | 1 | Oct 31, 2011 | clinicaltrials |
| NCT01214681 | Chemoprevention of Colorectal Cancer: the Role of Non-digestible Carbohydrates | unknown | N/A | 75 | Newcastle UniversityOTHER | 1 | Oct 26, 2011 | clinicaltrials |
| NCT01070355 | Eicosapentaenoic Acid (EPA) for Treatment of Colorectal Cancer Liver Metastases(EMT) | completed | Phase 2 | 88 | University of LeedsOTHER | 1 | Oct 21, 2011 | clinicaltrials |
| NCT00046787 | Efficacy and Safety Study of OSI-211 (Liposomal Lurtotecan) to Treat Recurrent Small Cell Lung Cancer | completed | Phase 2 | 47 | Astellas Pharma IncINDUSTRY | 2 | Oct 20, 2011 | clinicaltrials |
| NCT00046800 | Study of OSI-211 vs. Topotecan in Patients With Relapsed Epithelial Ovarian Cancer | completed | Phase 2 | 80 | Astellas Pharma IncINDUSTRY | 2 | Oct 20, 2011 | clinicaltrials |
| NCT00932854 | A Clinical tRial of Endobronchial Ultrasound for the Diagnosis of MEDiastinal lymphadenopathY (REMEDY)(REMEDY) | unknown | N/A | 75 | University College London HospitalsOTHER | 1 | Oct 18, 2011 | clinicaltrials |
| NCT00122772 | CRP on Radiobiological and Clinical Studies on Viral-Induced Cancer's Response to Radiotherapy | completed | Phase 3 | 601 | International Atomic Energy AgencyOTHER_GOV | 11 | Oct 14, 2011 | clinicaltrials |
| NCT00513851 | Phase 1 Study of OSI-930 in Cancer Patients | completed | Phase 1 | 60 | Astellas Pharma IncINDUSTRY | 2 | Sep 27, 2011 | clinicaltrials |
| NCT00603356 | Phase I Study of OSI-930 and Erlotinib in Cancer Tumors | completed | Phase 1 | 60 | Astellas Pharma IncINDUSTRY | 2 | Sep 27, 2011 | clinicaltrials |
| NCT00931840 | A Study of EZN-2208 Administered With or Without Cetuximab in Patients With Metastatic Colorectal Carcinoma | unknown | Phase 2 | 220 | Enzon Pharmaceuticals, Inc.INDUSTRY | 5 | Sep 20, 2011 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials